Table of Contents 1 Atherosclerosis Drug Market Overview 1.1 Product Overview and Scope of Atherosclerosis Drug 1.2 Classification of Atherosclerosis Drug by Types 1.2.1 Global Atherosclerosis Drug Revenue Comparison by Types (2019-2024) 1.2.2 Global Atherosclerosis Drug Revenue Market Share by Types in 2018 1.2.3 Anti-platelet Medications 1.2.4 Cholesterol Lowering Medications 1.2.5 Fibric Acid and Omega-3 Fatty Acid Derivatives 1.2.6 Other 1.3 Global Atherosclerosis Drug Market by Application 1.3.1 Global Atherosclerosis Drug Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Retail Pharmacies 1.3.3 Hospital Pharmacies 1.3.4 Online Pharmacies 1.4 Global Atherosclerosis Drug Market by Regions 1.4.1 Global Atherosclerosis Drug Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Atherosclerosis Drug Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Atherosclerosis Drug Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Atherosclerosis Drug Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Atherosclerosis Drug Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Atherosclerosis Drug Status and Prospect (2014-2024) 1.5 Global Market Size of Atherosclerosis Drug (2014-2024) 2 Company Profiles 2.1 GlaxoSmithKline 2.1.1 Business Overview 2.1.2 Atherosclerosis Drug Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 GlaxoSmithKline Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 2.2 Mylan 2.2.1 Business Overview 2.2.2 Atherosclerosis Drug Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Mylan Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 2.3 Bayer 2.3.1 Business Overview 2.3.2 Atherosclerosis Drug Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Bayer Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 2.4 Sanofi 2.4.1 Business Overview 2.4.2 Atherosclerosis Drug Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Sanofi Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 2.5 Janssen Pharmaceuticals 2.5.1 Business Overview 2.5.2 Atherosclerosis Drug Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Janssen Pharmaceuticals Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 2.6 F. Hoffmann-La Roche 2.6.1 Business Overview 2.6.2 Atherosclerosis Drug Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 F. Hoffmann-La Roche Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 2.7 Pfizer 2.7.1 Business Overview 2.7.2 Atherosclerosis Drug Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Pfizer Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 2.8 Merck & Co 2.8.1 Business Overview 2.8.2 Atherosclerosis Drug Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Merck & Co Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 2.9 Novartis 2.9.1 Business Overview 2.9.2 Atherosclerosis Drug Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Novartis Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 2.10 Amgen Inc 2.10.1 Business Overview 2.10.2 Atherosclerosis Drug Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 Amgen Inc Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) 3 Global Atherosclerosis Drug Market Competition, by Players 3.1 Global Atherosclerosis Drug Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Atherosclerosis Drug Players Market Share 3.2.2 Top 10 Atherosclerosis Drug Players Market Share 3.3 Market Competition Trend 4 Global Atherosclerosis Drug Market Size by Regions 4.1 Global Atherosclerosis Drug Revenue and Market Share by Regions 4.2 North America Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 4.3 Europe Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 4.5 South America Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 5 North America Atherosclerosis Drug Revenue by Countries 5.1 North America Atherosclerosis Drug Revenue by Countries (2014-2019) 5.2 USA Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 5.3 Canada Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 5.4 Mexico Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 6 Europe Atherosclerosis Drug Revenue by Countries 6.1 Europe Atherosclerosis Drug Revenue by Countries (2014-2019) 6.2 Germany Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 6.3 UK Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 6.4 France Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 6.5 Russia Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 6.6 Italy Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Atherosclerosis Drug Revenue by Countries 7.1 Asia-Pacific Atherosclerosis Drug Revenue by Countries (2014-2019) 7.2 China Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 7.3 Japan Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 7.4 Korea Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 7.5 India Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 8 South America Atherosclerosis Drug Revenue by Countries 8.1 South America Atherosclerosis Drug Revenue by Countries (2014-2019) 8.2 Brazil Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 8.3 Argentina Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 8.4 Colombia Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Atherosclerosis Drug by Countries 9.1 Middle East and Africa Atherosclerosis Drug Revenue by Countries (2014-2019) 9.2 Saudi Arabia Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 9.3 UAE Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 9.4 Egypt Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 9.5 Nigeria Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 9.6 South Africa Atherosclerosis Drug Revenue and Growth Rate (2014-2019) 10 Global Atherosclerosis Drug Market Segment by Type 10.1 Global Atherosclerosis Drug Revenue and Market Share by Type (2014-2019) 10.2 Global Atherosclerosis Drug Market Forecast by Type (2019-2024) 10.3 Anti-platelet Medications Revenue Growth Rate (2014-2024) 10.4 Cholesterol Lowering Medications Revenue Growth Rate (2014-2024) 10.5 Fibric Acid and Omega-3 Fatty Acid Derivatives Revenue Growth Rate (2014-2024) 10.6 Other Revenue Growth Rate (2014-2024) 11 Global Atherosclerosis Drug Market Segment by Application 11.1 Global Atherosclerosis Drug Revenue Market Share by Application (2014-2019) 11.2 Atherosclerosis Drug Market Forecast by Application (2019-2024) 11.3 Retail Pharmacies Revenue Growth (2014-2019) 11.4 Hospital Pharmacies Revenue Growth (2014-2019) 11.5 Online Pharmacies Revenue Growth (2014-2019) 12 Global Atherosclerosis Drug Market Size Forecast (2019-2024) 12.1 Global Atherosclerosis Drug Market Size Forecast (2019-2024) 12.2 Global Atherosclerosis Drug Market Forecast by Regions (2019-2024) 12.3 North America Atherosclerosis Drug Revenue Market Forecast (2019-2024) 12.4 Europe Atherosclerosis Drug Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Atherosclerosis Drug Revenue Market Forecast (2019-2024) 12.6 South America Atherosclerosis Drug Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Atherosclerosis Drug Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Atherosclerosis Drug Picture Table Product Specifications of Atherosclerosis Drug Table Global Atherosclerosis Drug and Revenue (Million USD) Market Split by Product Type Figure Global Atherosclerosis Drug Revenue Market Share by Types in 2018 Figure Anti-platelet Medications Picture Figure Cholesterol Lowering Medications Picture Figure Fibric Acid and Omega-3 Fatty Acid Derivatives Picture Figure Other Picture Table Global Atherosclerosis Drug Revenue (Million USD) by Application (2014-2024) Figure Atherosclerosis Drug Revenue Market Share by Applications in 2018 Figure Retail Pharmacies Picture Figure Hospital Pharmacies Picture Figure Online Pharmacies Picture Table Global Market Atherosclerosis Drug Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Atherosclerosis Drug Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Atherosclerosis Drug Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Atherosclerosis Drug Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Atherosclerosis Drug Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Atherosclerosis Drug Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Atherosclerosis Drug Revenue (Million USD) and Growth Rate (2014-2024) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Atherosclerosis Drug Type and Applications Table GlaxoSmithKline Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table Mylan Basic Information, Manufacturing Base and Competitors Table Mylan Atherosclerosis Drug Type and Applications Table Mylan Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table Bayer Basic Information, Manufacturing Base and Competitors Table Bayer Atherosclerosis Drug Type and Applications Table Bayer Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Atherosclerosis Drug Type and Applications Table Sanofi Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Janssen Pharmaceuticals Atherosclerosis Drug Type and Applications Table Janssen Pharmaceuticals Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors Table F. Hoffmann-La Roche Atherosclerosis Drug Type and Applications Table F. Hoffmann-La Roche Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Atherosclerosis Drug Type and Applications Table Pfizer Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table Merck & Co Basic Information, Manufacturing Base and Competitors Table Merck & Co Atherosclerosis Drug Type and Applications Table Merck & Co Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Atherosclerosis Drug Type and Applications Table Novartis Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table Amgen Inc Basic Information, Manufacturing Base and Competitors Table Amgen Inc Atherosclerosis Drug Type and Applications Table Amgen Inc Atherosclerosis Drug Revenue, Gross Margin and Market Share (2017-2018) Table Global Atherosclerosis Drug Revenue (Million USD) by Players (2014-2019) Table Global Atherosclerosis Drug Revenue Share by Players (2014-2019) Figure Global Atherosclerosis Drug Revenue Share by Players in 2017 Figure Global Atherosclerosis Drug Revenue Share by Players in 2018 Figure Global Top 5 Players Atherosclerosis Drug Revenue Market Share in 2018 Figure Global Top 10 Players Atherosclerosis Drug Revenue Market Share in 2018 Figure Global Atherosclerosis Drug Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Atherosclerosis Drug Revenue (Million USD) by Regions (2014-2019) Table Global Atherosclerosis Drug Revenue Market Share by Regions (2014-2019) Figure Global Atherosclerosis Drug Revenue Market Share by Regions (2014-2019) Figure Global Atherosclerosis Drug Revenue Market Share by Regions in 2018 Figure North America Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Europe Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure South America Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Table North America Atherosclerosis Drug Revenue by Countries (2014-2019) Table North America Atherosclerosis Drug Revenue Market Share by Countries (2014-2019) Figure North America Atherosclerosis Drug Revenue Market Share by Countries (2014-2019) Figure North America Atherosclerosis Drug Revenue Market Share by Countries in 2018 Figure USA Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Canada Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Mexico Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Table Europe Atherosclerosis Drug Revenue (Million USD) by Countries (2014-2019) Figure Europe Atherosclerosis Drug Revenue Market Share by Countries (2014-2019) Figure Europe Atherosclerosis Drug Revenue Market Share by Countries in 2018 Figure Germany Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure UK Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure France Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Russia Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Italy Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Table Asia-Pacific Atherosclerosis Drug Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Atherosclerosis Drug Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Atherosclerosis Drug Revenue Market Share by Countries in 2018 Figure China Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Japan Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Korea Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure India Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Southeast Asia Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Table South America Atherosclerosis Drug Revenue by Countries (2014-2019) Table South America Atherosclerosis Drug Revenue Market Share by Countries (2014-2019) Figure South America Atherosclerosis Drug Revenue Market Share by Countries (2014-2019) Figure South America Atherosclerosis Drug Revenue Market Share by Countries in 2018 Figure Brazil Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Argentina Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Colombia Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Table Middle East and Africa Atherosclerosis Drug Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Atherosclerosis Drug Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Atherosclerosis Drug Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Atherosclerosis Drug Revenue Market Share by Countries in 2018 Figure Saudi Arabia Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure UAE Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Egypt Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure Nigeria Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Figure South Africa Atherosclerosis Drug Revenue and Growth Rate (2014-2019) Table Global Atherosclerosis Drug Revenue (Million USD) by Type (2014-2019) Table Global Atherosclerosis Drug Revenue Share by Type (2014-2019) Figure Global Atherosclerosis Drug Revenue Share by Type (2014-2019) Figure Global Atherosclerosis Drug Revenue Share by Type in 2018 Table Global Atherosclerosis Drug Revenue Forecast by Type (2019-2024) Figure Global Atherosclerosis Drug Market Share Forecast by Type (2019-2024) Figure Global Anti-platelet Medications Revenue Growth Rate (2014-2019) Figure Global Cholesterol Lowering Medications Revenue Growth Rate (2014-2019) Figure Global Fibric Acid and Omega-3 Fatty Acid Derivatives Revenue Growth Rate (2014-2019) Figure Global Other Revenue Growth Rate (2014-2019) Table Global Atherosclerosis Drug Revenue by Application (2014-2019) Table Global Atherosclerosis Drug Revenue Share by Application (2014-2019) Figure Global Atherosclerosis Drug Revenue Share by Application (2014-2019) Figure Global Atherosclerosis Drug Revenue Share by Application in 2018 Table Global Atherosclerosis Drug Revenue Forecast by Application (2019-2024) Figure Global Atherosclerosis Drug Market Share Forecast by Application (2019-2024) Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019) Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019) Figure Global Online Pharmacies Revenue Growth Rate (2014-2019) Figure Global Atherosclerosis Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Atherosclerosis Drug Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Atherosclerosis Drug Revenue Market Share Forecast by Regions (2019-2024) Figure North America Atherosclerosis Drug Revenue Market Forecast (2019-2024) Figure Europe Atherosclerosis Drug Revenue Market Forecast (2019-2024) Figure Asia-Pacific Atherosclerosis Drug Revenue Market Forecast (2019-2024) Figure South America Atherosclerosis Drug Revenue Market Forecast (2019-2024) Figure Middle East and Africa Atherosclerosis Drug Revenue Market Forecast (2019-2024)

GlaxoSmithKline Mylan Bayer Sanofi Janssen Pharmaceuticals F. Hoffmann-La Roche Pfizer Merck & Co Novartis Amgen Inc